IncFact
Company Profiles: Revenue, Growth, Competition

AIM ImmunoTech Revenue, Growth & Competitor Profile

DBA HEMISPHERX BIOPHARMA, INC.
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for AIM ImmunoTech

Access the complete profile.

AIM ImmunoTech Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address2117 Sw Highway 484
Ocala, FL 32801

Note: Revenues for privately held companies are statistical evaluations.


AIM ImmunoTech's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • AIM ImmunoTech is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

AIM ImmunoTech Annual Revenue and Growth Rate

AIM ImmunoTech Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $10 - $100 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: AIM ImmunoTech's revenues are gauged from an analysis of company filings.



AIM ImmunoTech's Income Statement (based on Industry Averages)

AIM ImmunoTech P&L$ Millions
Revenue (Sales) AIM ImmunoTech Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that AIM ImmunoTech is developing and marketing. AIM ImmunoTech doesn't have any recent trademark applications, indicating AIM ImmunoTech is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
AIM
Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant
02/07/2020
AMPLIFIED IMMUNO MODULATION INC.
Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant
08/22/2019
HEMISPHERX
Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS
06/07/2019

See all trademarks and details in the Full Report.


Market Share of AIM ImmunoTech's Largest Competitors

A competitive analysis shows these companies are in the same general field as AIM ImmunoTech, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
AMERISOURCEBERGENConshohocken, PA100 
MCKESSONIrving, TX58 
CARDINAL HEALTH 119Dublin, OH42 
TAKEDA PHARMACEUTICALS AMERICALexington, MA31 
CATALENT PHARMA SOLUTIONSSomerset, NJ13 
OWENS & MINOR DISTRIBUTIONMechanicsville, VA11 
J M SMITHSpartanburg, SC3 
DAIICHI SANKYOBasking Ridge, NJ3 
HIKMA PHARMACEUTICALS USABerkeley Heights, NJ2 




Nearby Competitors

These companies are similar in business line and location to AIM ImmunoTech. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
XECOrlando, FL100 
JUBILANT DRAXIMAGE RADIOPHARMACIESOrlando, FL22 
AIM IMMUNOTECHOcala, FL6 
PRO SKIN SOLUTIONSOrlando, FL2 
STAR-LIGHT CREATIONSOrlando, FL1 




Future Competition: AIM ImmunoTech's Fastest Growing Competitors

These companies are in the same general field as AIM ImmunoTech and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
AIM ImmunoTech Competitors